Archer Materials LimitedASX: AXE

Early Pre-Pilot Study Advances Potassium Biosensor

· Issued by Archer Materials Limited

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Archer Materials Limited reports on an early-stage blood collection study for its potassium Biosensor, highlighting its significance in developing an integrated testing system. The study involved evaluating different blood collection methods to minimize haemolysis, which can affect potassium measurement accuracy. Results indicate a promising capillary collection method that produced low haemolysis levels, comparable to conventional methods, aiding future prototype development. The findings will inform the design of upcoming pilot studies and regulatory submissions, including to the FDA.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Archer Materials Limited on 6ix

Earlier from Archer Materials

Later from Archer Materials

All Archer Materials news releases